Abbvie Patient Assistance Foundation

Investigator-Initiated Studies (IIS) Program

Who can apply: Investigators may submit proposals involving AbbVie-associated products and therapeutic areas of interest. Studies generally require the relevant compound or product to have regulatory approval in the country of interest, where specified. Proposals are evaluated for scientific merit, alignment with AbbVie research interests and available funding. Some areas note that limited funds may be available. Submission does not guarantee approval, and support is contingent on execution of a research agreement.

Deadline: Applications accepted on a rolling submission basis.